SCHEMBL4349059

SCHEMBL4349059

O=C(Nc1ccc(C(F)(F)F)cc1)Nc1cc(Cl)cc(Cl)c1O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.63
EPHX2 P34913 2/20 0.59
CHRNA7 P36544 1/20 0.54
BAZ1A Q9NRL2 1/20 0.53
CA12 O43570 4/20 0.53
CA1 P00915 4/20 0.53
CA2 P00918 4/20 0.53
CA9 Q16790 4/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
MAPT P10636 2/20 0.52
HTT P42858 1/20 0.52
RAB9A P51151 1/20 0.52
NTRK1 P04629 1/20 0.52
CDK19 Q9BWU1 1/20 0.52
TRPV1 Q8NER1 1/20 0.51
P2RX1 P51575 1/20 0.50
P2RX4 Q99571 1/20 0.50
P2RX7 Q99572 1/20 0.50
TMPRSS4 Q9NRS4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3671992 0.86 CHRNA7 (0.72) CHRNA7MEN1KMT2AMAPTNTRK1
SCHEMBL4348490 0.86 GRIK1 (0.59) GRIK1EPHX2CA12CA1CA2
SCHEMBL4348880 0.84 EPHX2 (0.69) GRIK1EPHX2CHRNA7BAZ1ACA12
SCHEMBL6229028 0.84 MTOR (0.56) GRIK1CHRNA7MEN1KMT2AMAPT
SCHEMBL4354217 0.84 MAPT (0.53) GRIK1MEN1KMT2AMAPTHTT
SCHEMBL4354666 0.83 EPHX2 (0.62) EPHX2MEN1KMT2AMAPTHTT
SCHEMBL4356017 0.83 GRIK1 (0.56) GRIK1EPHX2CHRNA7BAZ1ACA12
SCHEMBL4351128 0.82 EPHX2 (0.61) GRIK1EPHX2BAZ1ACA12CA1
SCHEMBL4346945 0.82 NTRK1 (0.74) GRIK1EPHX2CHRNA7BAZ1ACA12
SCHEMBL4350084 0.82 MTOR (0.56) GRIK1EPHX2CHRNA7MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 GRIK1 21/4885EPHX2 769/4885CHRNA7 416/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 GRIK1 54/4885EPHX2 627/4885CHRNA7 700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.